Header Logo

Connection

Rosemarie Martin to Substance-Related Disorders

Back to Details
This is a "connection" page, showing publications Rosemarie Martin has written about Substance-Related Disorders.
Rosemarie Martin
Connection Strength
1.926
Substance-Related Disorders
  1. Bassett SS, Stein LA, Rossi JS, Martin RA. Evaluating Measures of Fidelity for Substance Abuse Group Treatment With Incarcerated Adolescents. J Subst Abuse Treat. 2016 07; 66:9-15.
    View in: PubMed
    Score: 0.294
  2. Martin RA, Cassidy RN, Murphy CM, Rohsenow DJ. Barriers to Quitting Smoking Among Substance Dependent Patients Predict Smoking Cessation Treatment Outcome. J Subst Abuse Treat. 2016 May; 64:7-12.
    View in: PubMed
    Score: 0.293
  3. Martin RA, Stein LA, Clair M, Cancilliere MK, Hurlbut W, Rohsenow DJ. Adolescent Substance Treatment Engagement Questionnaire for Incarcerated Teens. J Subst Abuse Treat. 2015 Oct; 57:49-56.
    View in: PubMed
    Score: 0.277
  4. Scott K, Salas MDH, Bayles D, Sanchez R, Martin RA, Becker SJ. Substance use workforce training needs during intersecting epidemics: an analysis of events offered by a regional training center from 2017 to 2020. BMC Public Health. 2022 05 28; 22(1):1063.
    View in: PubMed
    Score: 0.113
  5. Murphy CM, Martin RA, Tidey JW, Colby SM, Rohsenow DJ. Smoking outcome expectancies predict smoking during voucher-based treatment for smokers with substance use disorders. J Subst Abuse Treat. 2018 07; 90:73-78.
    View in: PubMed
    Score: 0.085
  6. van den Berg JJ, Adeyemo S, Roberts MB, Bock BC, Stein LAR, Martin RA, Parker DR, Clarke JG. Comparing the Validity of Self-Report and Urinalysis for Substance Use among Former Inmates in the Northeastern United States. Subst Use Misuse. 2018 08 24; 53(10):1756-1761.
    View in: PubMed
    Score: 0.084
  7. Rohsenow DJ, Tidey JW, Martin RA, Colby SM, Swift RM, Leggio L, Monti PM. Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms. Addiction. 2017 Oct; 112(10):1808-1820.
    View in: PubMed
    Score: 0.081
  8. Murphy CM, MacKillop J, Martin RA, Tidey JW, Colby SM, Rohsenow DJ. Effects of varenicline versus transdermal nicotine replacement therapy on cigarette demand on quit day in individuals with substance use disorders. Psychopharmacology (Berl). 2017 Aug; 234(16):2443-2452.
    View in: PubMed
    Score: 0.080
  9. Rohsenow DJ, Martin RA, Tidey JW, Colby SM, Monti PM. Treating Smokers in Substance Treatment With Contingent Vouchers, Nicotine Replacement and Brief Advice Adapted for Sobriety Settings. J Subst Abuse Treat. 2017 01; 72:72-79.
    View in: PubMed
    Score: 0.076
  10. Mackillop J, Murphy CM, Martin RA, Stojek M, Tidey JW, Colby SM, Rohsenow DJ. Predictive Validity of a Cigarette Purchase Task in a Randomized Controlled Trial of Contingent Vouchers for Smoking in Individuals With Substance Use Disorders. Nicotine Tob Res. 2016 May; 18(5):531-7.
    View in: PubMed
    Score: 0.072
  11. Rohsenow DJ, Tidey JW, Martin RA, Colby SM, Sirota AD, Swift RM, Monti PM. Contingent vouchers and motivational interviewing for cigarette smokers in residential substance abuse treatment. J Subst Abuse Treat. 2015 Aug; 55:29-38.
    View in: PubMed
    Score: 0.069
  12. Rohsenow DJ, Tidey JW, Kahler CW, Martin RA, Colby SM, Sirota AD. Intolerance for withdrawal discomfort and motivation predict voucher-based smoking treatment outcomes for smokers with substance use disorders. Addict Behav. 2015 Apr; 43:18-24.
    View in: PubMed
    Score: 0.067
  13. Bernstein MH, McSheffrey SN, van den Berg JJ, Vela JE, Stein LA, Roberts MB, Martin RA, Clarke JG. The association between impulsivity and alcohol/drug use among prison inmates. Addict Behav. 2015 Mar; 42:140-3.
    View in: PubMed
    Score: 0.067
  14. Stein LA, Clair M, Rossi JS, Martin RA, Cancilliere MK, Clarke JG. Gender, ethnicity and race in incarcerated and detained youth: services and policy implications for girls. Psychiatr Rehabil J. 2015 Mar; 38(1):65-73.
    View in: PubMed
    Score: 0.066
  15. Stein LA, Clair M, Martin RA, Soenksen S, Lebeau R, Rohsenow DJ, Kahler CW, Hurlbut W, Monti PM. Measuring behaviors of individual adolescents during group-based substance abuse intervention. Subst Abus. 2014; 35(4):408-17.
    View in: PubMed
    Score: 0.063
  16. Rohsenow DJ, Martin RA, Tidey JW, Monti PM, Colby SM. Comparison of the cigarette dependence scale with four other measures of nicotine involvement: correlations with smoking history and smoking treatment outcome in smokers with substance use disorders. Addict Behav. 2013 Aug; 38(8):2409-13.
    View in: PubMed
    Score: 0.060
  17. Zywiak WH, Neighbors CJ, Martin RA, Johnson JE, Eaton CA, Rohsenow DJ. The Important People Drug and Alcohol interview: psychometric properties, predictive validity, and implications for treatment. J Subst Abuse Treat. 2009 Apr; 36(3):321-30.
    View in: PubMed
    Score: 0.044
  18. Rohsenow DJ, Colby SM, Martin RA, Monti PM. Nicotine and other substance interaction expectancies questionnaire: relationship of expectancies to substance use. Addict Behav. 2005 May; 30(4):629-41.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.